ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

ClinicalTrials.gov ID: NCT05397639

Public ClinicalTrials.gov record NCT05397639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Study identification

NCT ID
NCT05397639
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Suven Life Sciences Limited
Industry
Enrollment
375 participants

Conditions and interventions

Interventions

  • Masupirdine 100 mg Drug
  • Masupirdine 50 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2022
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Jan 11, 2026

2022 – 2026

United States locations

U.S. sites
27
U.S. states
9
U.S. cities
20
Facility City State ZIP Site status
Advanced Research Center, Inc. Anaheim California 92805-5854 Recruiting
ATP Clinical Research, Inc. Costa Mesa California 92626-4607 Recruiting
Leading Edge Research LA, LLC Encino California 91316 Recruiting
Neuro Pain Medical Center Fresno California 93710-5473 Recruiting
Neurology Center of North Orange County Fullerton California 92835-1040 Recruiting
Mary S Easton Center for Alzheimer's Research and Care UCLA Los Angeles California 90095 Recruiting
Ki Health Partners, LLC Stamford Connecticut 06905 Recruiting
Allied Biomedical Research Institute Miami Florida 33125-2607 Recruiting
Central Miami Medical Institute Miami Florida 33125 Recruiting
CCM Clinical Research Group Miami Florida 33133 Recruiting
Miami Jewish Health Miami Florida 33137 Recruiting
Novel Clinical Research Center, LLC. Miami Florida 33143 Recruiting
Brainstorm Research Miami Florida 33176 Recruiting
Combined Research Orlando Phase I-IV Orlando Florida 32807 Recruiting
Quantum Laboratories Inc Pompano Beach Florida 33064 Recruiting
Re:Cognition Health Chicago Illinois 60611 Recruiting
Insight Hospital and Medical Center Chicago Chicago Illinois 60616 Recruiting
Ocean Medical Research Toms River New Jersey 08755 Recruiting
Dent Neurologic Institute Amherst New York 14226 Recruiting
Velocity Clinical Research, Syracuse East Syracuse New York 13057 Recruiting
Velocity Clinical Research, Cleveland Beachwood Ohio 44122 Recruiting
Ralph H. Johnson VA Health Care System Charleston South Carolina 29401-1113 Recruiting
Midlands Neurology and Pain Associates Columbia South Carolina 29205 Recruiting
Gadolin Research Beaumont Texas 77702 Recruiting
Re:Cognition Health Fort Worth Texas 76104 Recruiting
Baylor College of Medicine Houston Texas 77030-4202 Recruiting
Clinical Trial Network Houston Texas 77074 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05397639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05397639 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →